Dallas, Texas 02/10/2014 (FINANCIALSTRENDS) – The last trading session saw Buka Ventures Inc (OTCBB:NNRX) plunging to -7.37% and the stock price was closed at $0.352. The total volume of shares that were traded in that day was 617,741.00 shares. If we talk about the average trading volume of Buka Ventures Inc. then it is around 2.39 million. The 52 week high of this share is $ 1.48 and its 52 week low is around $0.12. The last trading session saw Buka Ventures touching $0.33.
Recently Buka Ventures Inc (OTCBB:NNRX) had a very tough time when for three months the stock took a heavy beating and dropped from its September high of $1.43 to a sad low of $0.47. But now things seem to be looking prettier as Southridge Partners II, LP has shown some interest in the stock and might buy 10 percent stake in Buka Ventures. Southridge Partners LP is a Delaware based limited partnership firm. Buka Ventures also announced that the company has recently completed a license agreement with Genesar Nutraceuticals, LLC and acquired rights to market and distribute the GenEpic which is a natural therapeutic formula for treating prostate cancer and its recovery.
An Overview of Buka Ventures Inc (OTCBB:NNRX)
Buka Ventures Inc. also called as Nutranomics develops and researches various nutritional food products and offers a wide range of nutritional supplements for joint health, hormone imbalance, digestive enzymes, stress/sleep, natural vitamin C and few natural antiviral also.
Buka Ventures Inc. was acquired by Nutranomics under a reverse merger transaction. Recently the company has announced that it is actively looking for strategic partners for more growth. Though this stock now belongs to the list of penny stocks but there are many investment and trading firms which believe that there is still some juice left in this stock and investment in this stock can fetch short to medium term gains to the tune of 5 to 9 percent.